Huifeng Bio-Pharmaceutical Technology, Inc. to Attend 2011 CPhI Frankfurt
XI'AN, China, Oct. 10, 2011 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Pink: HFGB) ("Huifeng" or the "Company"), a Xi'an, China-based developer and producer of botanical extracts and other raw materials used in pharmaceuticals and food additives, today announced its subsidiary Shaanxi Huifeng Pharmaceutical Ltd. will attend the CPhI Worldwide Frankfurt 2011 in Germany.
The three-day event will take place from October 25-27 at the Messe Frankfurt exhibition grounds, located at Ludwig-Ernhard-Anlage 1, Frankfurt am Main, Germany, 60327. Huifeng's booth number will be 31C23 and located in Hall 3.1. Shaanxi Huifeng Pharmaceutical Ltd. has obtained Diosmin COS certificate in May, 2011. In this event, Huifeng plans to showcase its Diosmin and Rutin series products including Rutin NF11, Rutin DAB10, EP7, Troxerutin EP7, Quercetin, Rhamnose.
"We are really looking forward to attending the 2011 CPhI Worldwide Conference," said Huifeng's Founder, Executive Chairman and CEO, Jing'an Wang. "It will be a great opportunity to meet with customers and other businesses from around the globe, and to talk with them about the industry in general and our products' competitive advantages in particular. Attending CPhI's recent exhibition in Shanghai, China was an excellent learning experience for us, and we believe that CPhI's upcoming event in Frankfurt, Germany will provide us with even greater opportunities to enrich our understanding of the current landscape of the pharmaceutical and health care sectors. Moreover, we are thrilled to have the opportunities at the conference to market our flagship products, Rutin series product and Diosmin, and to increase overall customer awareness."
About Huifeng Bio-Pharmaceutical Technology, Inc.Huifeng Bio-Pharmaceutical Technology, Inc. is a Xi'an, China-based Company engaged in the production and supply of high quality plant extracts and raw materials used to produce pha